| Unique ID issued by UMIN | UMIN000056270 |
|---|---|
| Receipt number | R000064131 |
| Scientific Title | Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis: An Infant Cohort Study |
| Date of disclosure of the study information | 2024/12/01 |
| Last modified on | 2024/11/13 10:49:17 |
Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis
Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis
Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis: An Infant Cohort Study
Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis
| Japan |
Atopic Dermatitis/Eczema
| Pediatrics | Dermatology |
Others
YES
Investigating the intestinal/skin environment and blood markers of infants associated with the development of atopic dermatitis in infants with eczema.
Others
Investigating the intestinal/skin environment and blood markers of infants associated with the development of atopic dermatitis in infants with eczema.
No medical efficacy or safety evaluations will be conducted in this study.
Observational
| 2 | weeks-old | <= |
| 14 | months-old | > |
Male and Female
(1) Male and female infants aged 0-1 month who have skin problems such as infantile eczema upon visiting the clinic.
(2) Those whose guardians have received an explanation of the study, are able to understand its contents, and can provide written consent.
(1) Those with a history of serious illness.
(2) Those who have taken or applied antibiotics within one month prior to obtaining consent.
(3) Those who have treated eczema with medications other than moisturizers, such as steroids, before participating in the study.
(4) Those who are deemed ineligible by the study representative or principal investigator.
200
| 1st name | Shinji |
| Middle name | |
| Last name | Fukuda |
Keio University
Institute of Advanced Bioscience
9970052
246-2, Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan
0235-29-0528
sfukuda@sfc.keio.ac.jp
| 1st name | Shinji |
| Middle name | |
| Last name | Fukuda |
Keio University
Institute of Advanced Bioscience
9970052
246-2, Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan
0235-29-0528
sfukuda@sfc.keio.ac.jp
Keio University
Yamagata Prefectural Government and the City of Tsuruoka
Local Government
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Sanwauchikanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo, Japan
03-5297-5548
IRB@cpcc.co.jp
NO
内野産婦人科外科小児科(東京都)
産婦人科小児科三井病院(山形県)
| 2024 | Year | 12 | Month | 01 | Day |
Unpublished
Preinitiation
| 2024 | Year | 07 | Month | 26 | Day |
| 2024 | Year | 07 | Month | 26 | Day |
| 2024 | Year | 12 | Month | 02 | Day |
| 2026 | Year | 12 | Month | 31 | Day |
Research design: Cohort Study (Exploratory)
Recruitment method: The physician in charge at the cooperating institutions will explain the study to the guardians of patients who have been diagnosed with skin problems and obtain their consent. Those who have agreed to participate in the study of their guardians' free will, meet the selection criteria, and do not violate the exclusion criteria will be included in the study.
Recruitment period (expected): A year from December 2024
| 2024 | Year | 11 | Month | 25 | Day |
| 2024 | Year | 11 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064131